Photo from wikipedia
There is a scarcity of data about patients with pancreatic ductal adenocarcinoma (PDAC) who received neoadjuvant therapy before radical resection and achieved a pathological complete response (pCR). The aim of… Click to show full abstract
There is a scarcity of data about patients with pancreatic ductal adenocarcinoma (PDAC) who received neoadjuvant therapy before radical resection and achieved a pathological complete response (pCR). The aim of this study was to describe the recurrence and survival in this subset of patients.
Keywords:
pathological complete;
neoadjuvant therapy;
pancreatic ductal;
ductal adenocarcinoma;
complete response
Journal Title: ANZ Journal of Surgery
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: ANZ Journal of Surgery
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!